Trial Profile
Active Preoperative Anemia Management to Reduce Erythrocyte Transfusion in Patients Undergoing Cardiac Surgery (APART): A Pilot, Feasibility Study
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary) ; Erythropoietin
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms APART
- 24 Sep 2019 Status changed from recruiting to discontinued.
- 07 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2020.
- 07 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.